The briefing
A targeted RNA therapy that elevates VEGF‑A in transplanted beta cells is reported to speed blood-vessel growth. The approach improved islet survival and glucose regulation in Type 1 diabetes models, pointing to a potential new treatment avenue.
Original headline
Improving Diabetes Treatment Through RNA Technology